Sort

Search

22/02/2022 European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
Bataller, A, Garrido, A, Guijarro, F, Onate, G, Diaz-Beya, M, Arnan, M, Tormo, M, Vives, S, de Llano, MPQ, Coll, R, Gallardo, D, Vall-Llovera, F, Escoda, L, Garcia-Guinon, A, Salamero, O, Sampol, A, Merchan, BM, Bargay, J, Castano-Diez, S, Esteban, D, Oliver-Caldes, A, Rivero, A, Mozas, P, Lopez-Guerra, M, Pratcorona, M, Zamora, L, Costa, D, Rozman, M, Nomdedeu, JF, Colomer, D, Brunet, S, Sierra, J, Esteve, J. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood Advances. 2022; 6(4)DOI:10.1182/bloodadvances.2021005585. PMID:34911079. IF:7.500(Q1/2D).
21/02/2022 Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus
Stocchi, F, Antonini, A, Berg, D, Bergmans, B, Jost, W, Katzenschlager, R, Kulisevsky, J, Odin, P, Valldeoriola, F, Chaudhuri, KR. Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus. npj Parkinsons Disease. 2022; 8(1)DOI:10.1038/s41531-022-00277-z. PMID:35190544. IF:8.700(Q1/1D).
19/02/2022 Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area
Malmusi, D, Pasarin, MI, Mari-Dell'Olmo, M, Artazcoz, L, Diez, E, Tolosa, S, Rodriguez-Sanz, M, Perez, G, Pena-Gallardo, C, Borrell, C. Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area. International Journal for Equity in Health. 2022; 21(1)DOI:10.1186/s12939-022-01628-1. PMID:35183189. IF:4.800(Q1/2D).
18/02/2022 Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes
Arderiu, G, Pena, E, Civit-Urgell, A, Badimon, L. Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.836662. PMID:35251029. IF:7.300(Q1/3D).